This two-centre, open-label, crossover RCT investigated the glycaemic efficacy of HCL insulin therapy using the mylife CamAPS FX system with SMA vs CC in youth and young adults with type 1 diabetes. Here, INS is linked to type 1 diabetes mellitus.